NCT02743520

Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)

Early Identification of Patients With Coexisting Atrial Fibrillation and Obstructive Sleep Apnea

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 86 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 40 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research study is to learn about arrhythmia detection in obstructive sleep apnea (OSA). For several years patients with OSA have an increased likelihood of having irregular heartbeats. This study will determine how often patients with OSA have irregular heartbeats. This study will also define which OSA patients are most likely to have irregular heartbeats. The participant is being asked to be in the study because the participant has been diagnosed with obstructive sleep apnea (OSA).

Conditions

• Atrial Fibrillation
• Arrhythmia
• Stroke, Cardiovascular

Interventions

Type	Name	Description
DEVICE	The Lifestar Act III	The Lifestar Act III is a chest-worn continuous Electrocardiogram (ECG) monitor and arrhythmia detector. The device is equipped with four electrodes on a harness with a Bluetooth transceiver and a buzzer. The ECG signals will be transmitted via Bluetooth to an application arranged to process and transmit the ECG recordings.

Timeline

• Start date: 2017-03-06
• Primary completion: 2019-04-03
• Completion: 2019-04-03
• First posted: 2016-04-19
• Last updated: 2020-11-19
• Results posted: 2020-11-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study